Tiny probe tracks antibiotic in Kids' chests after heart surgery
NCT ID NCT07327502
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how the antibiotic cefazolin spreads in the chest tissue of 10 children after heart surgery for congenital heart disease. A small probe placed during surgery will measure drug levels over 36 hours. The goal is to create a computer model to help doctors give the best dose to prevent infections.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- cefazolin
- What this could lead to
- If successful, this could help doctors give the right dose of cefazolin to prevent infections after children's heart surgery.
- What could go wrong
- This is a very small, early study with only 10 children, so results may not apply to all kids. It only measures drug levels, not whether infections are actually prevented.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDREN IN CARDIAC INTENSIVE CARE REQUIRING SURGERY FOR CONGENITAL HEART DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Necker Enfants Malades
Paris, Île-de-France Region, 75015, France